NanoDimension, Inc.
Follow13F filer, CIK 1912801, Woodside, CA
NanoDimension, Inc. reported $45,599,000 across 4 holdings for the quarter ended 2022-03-31, in a 13F-HR filed 2022-05-11.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-22-058770
- Period
- 2022-03-31
- Reported value
- $45.6M
- Holdings
- 4
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Largest buys vs the previous quarter
None.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| ICOSAVAX INCreduced | -56,222 | -$396K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q1 2022
Share positions as resolved from 13F-HR 0001104659-22-058770, largest first. % of portfolio is the value over $45,599,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| ICOSAVAX INCICOSAVAX INC | 2,693,772 | $19M | 41.59% | -56,222 | |||
| TWSTTWIST BIOSCIENCE CORP | 307,740 | $15.2M | 33.33% | 0 | Timeline | ||
| SQZBSQZ BIOTECHNOLOGIES CO COM | 1,445,221 | $6.95M | 15.25% | 0 | Timeline | ||
| SELECTA BIOSCIENCES INCSELECTA BIOSCIENCES INC | 3,647,907 | $4.49M | 9.84% | 0 |
How Q1 2022 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001104659-22-058770 | base | 2022-05-11 | acceptance time not in the bulk data set |